- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/215 - Radicals derived from nitrogen analogues of carbonic acid
Patent holdings for IPC class C07D 295/215
Total number of patents in this class: 99
10-year publication summary
|
8
|
7
|
8
|
3
|
3
|
7
|
9
|
8
|
7
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Excir Works Corp. | 31 |
4 |
| Janssen Pharmaceutica N.V. | 3392 |
3 |
| Universita degli Studi di Milano-bicocca | 154 |
3 |
| Universita' degli Studi di Pavia | 73 |
3 |
| The Regents of the University of California | 19918 |
2 |
| Ricoh Company, Ltd. | 13247 |
2 |
| Chong Kun Dang Pharmaceutical Corp. | 233 |
2 |
| The Florida International University Board of Trustees | 619 |
2 |
| Heliatek GmbH | 131 |
2 |
| Immunomet Therapeutics Inc. | 31 |
2 |
| Merial, Inc. | 220 |
2 |
| Nabriva Therapeutics AG | 15 |
2 |
| Sigma-Aldrich Co., LLC | 255 |
2 |
| The United States of America, as represented by the Secretary, Department of Health & Human Services | 208 |
2 |
| Viamet Pharmaceuticals, Inc. | 39 |
2 |
| Chengdu Kaoensi Science and Technology Co., Ltd. | 2 |
2 |
| Corteva Agriscience LLC | 2669 |
2 |
| Chorda Pharma, Inc. | 5 |
2 |
| Reata Pharmaceuticals Holdings, LLC | 47 |
2 |
| Bristol-myers Squibb Company | 4898 |
1 |
| Other owners | 55 |